Early Mindfulness Based Cognitive Therapy for Prevention of Psychological Distress in Cancer Patients

The goal of this clinical trial is to learn if early provision of mindfulness based cognitive therapy can prevent psychological distress in adult patients with cancer one year after diagnosis.

Researchers will compare mindfulness based cognitive therapy to usual care to see if psychological distress is lower in patients that followed mindfulness.

Participants will follow 8 weekly sessions of mindfulness and fill in questionnaires.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cancer Mindfulness Based Cognitive Therapy Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosed with urological cancer or breast cancer
<6 weeks since cancer diagnosis
Planned curative treatment or palliative treatment with life expectation >1 year
Good proficiency in Dutch language

Exclusion criteria

Serious psychiatric history or current psychiatric treatment (interfering with study participation): 1) current suicidal ideation, 2) current psychosis or bipolar disorder, 3) psychosis or bipolar disorder in history
Unable to understand study procedure
A priori unable to be available for 8 week MBCT

Treatment and study plan

Mindfulness Based Stress Reduction

Behavioral

8 weekly sessions of 2.5 hour per session, face-to-face in a group consisting of maximum 15 participants, supervised by a certified mindfulness trainer

Other names: mindfulness, mindfulness therapy, MBCT

Primary outcomes

Psychological distress

Time frame: From enrollment to 2 years after diagnosis

Anxiety and depression as measured with the Hospital Anxiety and Depression Scale

Study contacts

Contact information is provided by the study sponsor or research team.

Eva Noorda, PhD

CONTACT

[email protected]

Marit Mentink, PhD

CONTACT

[email protected]

+31657643188

Sponsors and collaborators

Lead sponsor

Isala

Other

Collaborators

Helen Dowling Institute

Registry information

Acronym: EarlyMind

Important dates

Study start: 2025
Primary completion: 2027
Study completion: 2027
First posted: Aug 15, 2025
Registry last updated: Aug 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting